New Drug Shows Promise for Rare Blood Cancers

WEDNESDAY, June 29, 2016 — An experimental drug called midostaurin may reverse organ damage in people with certain rare, fatal blood cancers, an early clinical trial finds.
Researchers found that the drug at least partly reversed organ damage in 60…
Source: Topamax